Skip to content
Companies
Investors
Funds
People
Markets
/
Sign in
Join
Loading vertical…
By stage
Biotechnology Companies — Healthcare Market Data — Capbase
Markets
/
Healthcare
/ Biotechnology
Biotechnology
433
Companies
$1.5B
Capital raised
537
Disclosed deals
of 7,157 companies recorded
By stage
433 companies
Seed
· 153 companies · $172.9M
Company
Stage
Last valuation
Total raised
T
Tempest Therapeutics, Inc.
Tempest Therapeutics develops oral cancer therapies, led by Amezalpat (TPST-1120) for hepatocellular carcinoma.
Seed
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
Q
Qlaris Bio, Inc.
Qlaris Bio, Inc., co-founded in 2019 in Massachusetts, is a clinical-stage biotech developing the topical therapy QLS-111 for glaucoma.
Seed
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
C
Cyrus Biotechnology, Inc.
Won 3 federal SBIR/STTR research awards from HHS and other federal agencies.
Seed
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
H
HCW Biologics Inc.
HCW Biologics Inc., founded in 2018 in Miramar, Florida, is a preclinical biopharmaceutical company developing immunotherapies.
Seed
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
A
AKADEUM LIFE SCIENCES, INC.
Akadeum Life Sciences makes the Alerion microbubble cell separation system for cell therapy manufacturing and immunology research.
Seed
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
C
Cresilon, Inc.
Cresilon develops VETIGEL, a plant-based hemostatic gel that stops bleeding in animals, with plans for human medical use.
Seed
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
C
CND Life Sciences, Inc.
Won 4 federal SBIR/STTR research awards from HHS and other federal agencies.
Seed
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
E
Edesa Biotech, Inc.
Edesa Biotech develops monoclonal antibody candidates for immuno-inflammatory diseases such as ARDS from its base in Markham, Ontario.
Seed
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
B
BIOVENTRIX, INC.
BioVentrix, Inc. is a Massachusetts medical device company developing the Revivent TC System for transcatheter repair of the failing heart.
Seed
Last valuation
Undisclosed
Total raised
Sign in
G
GelMEDIX, Inc.
GelMEDIX, Inc., based in Cambridge, Massachusetts, develops ocular cell therapies aimed at restoring vision.
Seed
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
See all 153 →
Series A
· 71 companies · $443.1M
Company
Stage
Last valuation
Total raised
Q
Quince Therapeutics, Inc.
Quince Therapeutics, Inc., founded in 2012 in South San Francisco, is a biotechnology company that raised USD 485 million in 2023.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
Series B
· 16 companies · $274.9M
Company
Stage
Last valuation
Total raised
G
Gossamer Bio, Inc.
Gossamer Bio, Inc. is a San Diego biopharmaceutical company developing seralutinib for pulmonary arterial hypertension and PH-ILD.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
Series C
· 9 companies · $215.2M
Company
Stage
Last valuation
Total raised
D
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics develops small molecule therapies that target biomolecular condensates for neurodegenerative diseases and cancers.
Series C
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
Series D
· 3 companies · $351.9M
Company
Stage
Last valuation
Total raised
L
LISATA THERAPEUTICS, INC.
Private securities offering disclosed via SEC Form D.
Series D
Healthcare
Last valuation
Undisclosed
Total raised
$351.9M
E
Epicrispr Biotechnologies, Inc.
Late stage
· 158 companies
Company
Stage
Last valuation
Total raised
A
Artios Pharma Limited
UK private limited company incorporated 2015.
Late stage
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
V
Public
· 22 companies
Company
Stage
Last valuation
Total raised
A
Autolus Therapeutics PLC
UK public limited company incorporated 2018.
Public
Last valuation
Undisclosed
Total raised
Sign in
A
Acquired
· 1 company
Company
Stage
Last valuation
Total raised
C
CureVac
Biopharmaceutical company in Germany
Acquired
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
Sign in to see
6,724
more companies.
Sign in
E
Entact Bio, Inc.
Entact Bio, Inc., founded in 2022 in Watertown, Massachusetts, is a preclinical-stage biotechnology company.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
O
Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc., based in New Jersey, develops an ophthalmic formulation aimed at preserving vision.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
T
Tolerance Bio Inc.
Tolerance Bio, Inc., founded in 2023 in Pennsylvania, develops thymus-based therapies for immune-mediated diseases and immune aging.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
S
SPINEOLOGY INC
Spineology Inc., founded in 1997 in St. Paul, Minnesota, makes spinal implants, including the OptiMesh expandable interbody implant.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
I
Immunis, Inc.
Immunis, Inc., founded in 2019 in Irvine, California, is a biotech company developing treatments for age- and disease-related immune decline.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
R
REGENTIS BIOMATERIALS LTD.
Regentis Biomaterials develops GelrinC, a resorbable hydrogel implant for orthopedic tissue repair and regeneration.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
P
Potrero Medical, Inc.
Won a federal SBIR/STTR research award from HHS and other federal agencies.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
A
Avivomed Inc.
Avivomed Inc. develops implantable neuromodulation devices and therapy platforms for patients with chronic conditions.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
N
Nuclein, LLC
Nuclein, LLC, founded in 2017 in Austin, Texas, is developing a hand-held PCR test for infectious disease diagnosis.
Series A
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
See all 71 →
T
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. develops drugs that covalently bind lysine, with lead AKT1-selective inhibitor programs.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
V
Virtual Incision Corp
Virtual Incision develops the MIRA miniaturized robotic-assisted surgical system for procedures through small incisions.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
C
Cue Biopharma, Inc.
Cue Biopharma, Inc., based in Boston, develops engineered biologics that selectively activate specific immune cells.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
C
Contraline, Inc.
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
M
Magnus Medical, Inc.
Magnus Medical, based in Burlingame, California, develops the SAINT Neuromodulation System for adults with major depressive disorder.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
J
JASTLabs Corp
Private securities offering disclosed via SEC Form D.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
$50M
C
CURADEL SURGICAL INNOVATIONS, INC.
Private securities offering disclosed via SEC Form D.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
$49.8M
A
AXOFT, INC.
Axoft Inc., based in Massachusetts, develops implantable brain-computer interfaces for neurological disorders.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
E
Estuary Biotherapeutics, Inc.
Private securities offering disclosed via SEC Form D.
Series B
Healthcare
Last valuation
Undisclosed
Total raised
$40.7M
See all 16 →
L
Lycia Therapeutics, Inc.
Lycia Therapeutics develops LYTAC degraders that remove disease-causing extracellular proteins for autoimmune and inflammatory diseases.
Series C
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
C
Climb Bio, Inc.
Climb Bio, Inc., formerly Eliem Therapeutics, is a biotechnology company developing treatments for neuronal excitability disorders.
Series C
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
C
Cambrian BioPharma Inc
Cambrian BioPharma is a distributed drug discovery company that funds and partners with research teams on a portfolio of drug projects.
Series C
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
C
Cellanome, Inc.
Cellanome, Inc., founded in 2020 in California, is a biotechnology company that offers an automated platform for studying individual cells.
Series C
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
Q
Quanta Therapeutics, Inc.
Quanta Therapeutics develops allosteric KRAS inhibitors for RAS-driven cancers, with lead candidates in Phase 1 trials.
Series C
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
S
SonoThera, Inc.
SonoThera develops gene therapies delivered by sonoporation, a microbubble-based method that temporarily opens cell membranes.
Series C
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
S
Syncromune, Inc.
Private securities offering disclosed via SEC Form D.
Series C
Healthcare
Last valuation
Undisclosed
Total raised
$144.8M
F
FORE US Bio Inc.
Private securities offering disclosed via SEC Form D.
Series C
Healthcare
Last valuation
Undisclosed
Total raised
$70.4M
Epicrispr Biotechnologies develops ultracompact genetic medicines that modulate gene expression, using its GEMS platform.
Series D
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
O
Ollin Biosciences, Inc.
Ollin Biosciences develops therapies for severe eye diseases, including wet AMD, diabetic macular edema and thyroid eye disease.
Series D
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
Verdiva Bio Limited
UK private limited company incorporated 2024.
Late stage
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
A
Apollo Therapeutics Limited
UK private limited company incorporated 2021.
Late stage
Last valuation
Undisclosed
Total raised
Sign in
B
Beacon Therapeutics Limited
UK private limited company incorporated 2022.
Late stage
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
V
Verona Pharma Limited
UK private limited company incorporated 2005.
Late stage
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
Q
Quell Therapeutics Limited
UK private limited company incorporated 2019.
Late stage
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
T
Tenpoint Therapeutics Limited
UK private limited company incorporated 2020.
Late stage
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
O
Ottimo Pharma Limited
UK private limited company incorporated 2017.
Late stage
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
I
Inivata Limited
UK private limited company incorporated 2014.
Late stage
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
R
Resolution Therapeutics Limited
UK private limited company incorporated 2017.
Late stage
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
See all 158 →
Adaptimmune Therapeutics PLC
UK public limited company incorporated 2014.
Public
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
M
Mereo Biopharma Group PLC
UK public limited company incorporated 2015.
Public
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
S
Silence Therapeutics PLC
UK public limited company incorporated 1994.
Public
Healthcare
Last valuation
Undisclosed
Total raised
Sign in
A
Allied Minds PLC
UK public limited company incorporated 2014.
Public
Activities of venture and development capital companies
Last valuation
Undisclosed
Total raised
$0
B
Biocon Biologics Global PLC
UK public limited company incorporated 2024.
Public
Consumer & retail
Last valuation
Undisclosed
Total raised
$0
B
Biocon Biologics UK PLC
UK public limited company incorporated 2022.
Public
Industrials
Last valuation
Undisclosed
Total raised
$0
B
Biodexa Pharmaceuticals PLC
UK public limited company incorporated 2014.
Public
Healthcare
Last valuation
Undisclosed
Total raised
$0
B
BSF Enterprise PLC
UK public limited company incorporated 2018.
Public
Healthcare
Last valuation
Undisclosed
Total raised
$0
C
Coiled Therapeutics PLC
UK public limited company incorporated 2020.
Public
Healthcare
Last valuation
Undisclosed
Total raised
$0
See all 22 →